Loading...
 

Volume 35, Issue 1, March 2024



Sign in to download the Issue in PDF format.

Back to the list
Mediterr J Rheumatol 2024;35(1):195-6
Article Links
Transient Aortitis after COVID-19 mRNA Vaccination
Hiroaki Nishioka, Yuuki Okumura
Authors Information

Department of General Internal Medicine, Kobe City Medical Centre General Hospital, Kobe City, Hyogo, Japan

H Nishioka

Keywords: aortitis, COVID-19, mRNA-based vaccine
References
  1. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239–45.
  2. Tang X, Liu F, Li Q, Fu H, Wang J, Mao J. De Novo Vasculitis after COVID-19 Vaccination. Curr Rheumatol Rev 2023;19:151–8.
  3. Gilio M, De Stefano G. Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine. Intern Emerg Med 2022;17:1239–41.
  4. Katsouli OK, Lainis VG, Kapellos GG, Vlachoyiannopoulos PG. Large Vessel Vasculitis After the Administration of Oxford-AstraZeneca COVID-19 Vaccine. Mediterr J Rheumatol 2023;34(1):97–100.
  5. Aoki K, Yamamoto S, Tochitani K. Transient Large-vessel Vasculitis after COVID-19 mRNA Vaccination. Intern Med 2022;61:2083–4.
  6. Noda S, Hanai S, Ito R, Kobayashi Y, Nakagomi D. Isolated thoracic aortitis following mRNA vaccination against SARS-CoV-2. QJM 2023:hcad126. doi: 10.1093/qjmed/hcad126. Online ahead of print.
  7. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020;395:1033–4.
  8. Costello F, Dalakas MC. Cranial neuropathies and COVID-19: neurotropism and autoimmunity. Neurology 2020;95:195–6.
  9. Abu Hassan F, Abu Alhalawa M, Majdoubehv Y, Nepal A, Sufan SS. COVID-19 Aortitis: A Review of Published Cases. Cureus 2022;14:e22226.
  10. Zhang C, Maruggi G, Shan H, Li J. Advances in mRNA Vaccines for Infectious Diseases. Front Immunol 2019;10:594.
  11. Watad A, De Marco G, Mahajna H, Druyan A, Eltity M, Hijazi N, et al. Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA/DNA SARS-CoV-2 vaccination. Vaccines (Basel) 2021;9:435.